Literature DB >> 12600654

The first strand transfer reaction of HIV-1 reverse transcription is more efficient in infected cells than in cell-free natural endogenous reverse transcription reactions.

C William Hooker1, David Harrich.   

Abstract

BACKGROUND: In the presence of dNTPs, intact HIV-1 virions are capable of reverse transcribing at least part of their genome, a process known as natural endogenous reverse transcription (NERT). PCR analysis of virion DNA produced by NERT revealed that the first strand transfer reaction (1stST) was inefficient in intact virions, with minus strand (-) strong stop DNA (ssDNA) copy numbers up to 200 times higher than post-1stST products measured using primers in U3 and U5. This was in marked contrast to the efficiency of 1stST observed in single-round cell infection assays, in which (-) ssDNA and U3-U5 copy numbers were indistinguishable.
OBJECTIVES: To investigate the reasons for the discrepancy in first strand transfer efficiency between intact cell-free virus and the infection process. STUDY
DESIGN: Alterations of both NERT reactions and the conditions of cell infection were used to test whether uncoating and/or entry play a role in the discrepancy in first strand transfer efficiency. RESULTS AND
CONCLUSIONS: The difference in 1stST efficiency could not be attributed simply to viral uncoating, since addition of very low concentrations of detergent to NERT reactions removed the viral envelope without disrupting the reverse transcription complex, and these conditions resulted in no improvement in 1stST efficiency. Virus pseudotyped with surface glycoproteins from either vesicular stomatitis virus or amphotrophic murine leukaemia virus also showed low levels of 1stST in low detergent NERT assays and equivalent levels of (-) ssDNA and 1stST in single-round infections of cells, demonstrating that the gp120-mediated infection process did not select for virions capable of carrying out 1stST. These data indicate that a post-entry event or factor may be involved in efficient HIV-1 reverse transcription in vivo. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600654     DOI: 10.1016/s1386-6532(02)00121-x

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  A post-entry role for CD63 in early HIV-1 replication.

Authors:  Guangyu Li; Natallia Dziuba; Brian Friedrich; James L Murray; Monique R Ferguson
Journal:  Virology       Date:  2011-02-26       Impact factor: 3.616

Review 2.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

3.  Tetraspanin CD63 is a regulator of HIV-1 replication.

Authors:  Enqing Fu; Lei Pan; Yonghong Xie; Deguang Mu; Wei Liu; Faguang Jin; Xuefan Bai
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors.

Authors:  Kylie Warren; Ting Wei; Dongsheng Li; Fangyun Qin; David Warrilow; Min-Hsuan Lin; Haran Sivakumaran; Ann Apolloni; Catherine M Abbott; Alun Jones; Jenny L Anderson; David Harrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

5.  Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 during Early Stages of Infection.

Authors:  Alvaro E Galvis; Hugh E Fisher; Hung Fan; David Camerini
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

6.  Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.

Authors:  Daniel J Rawle; Dongsheng Li; Zhonglan Wu; Lu Wang; Marcus Choong; Mary Lor; Robert C Reid; David P Fairlie; Jonathan Harris; Gilda Tachedjian; Sally-Ann Poulsen; David Harrich
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

7.  Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro.

Authors:  David Warrilow; Luke Meredith; Adam Davis; Christopher Burrell; Peng Li; David Harrich
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

8.  Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.

Authors:  Dongsheng Li; Ting Wei; Daniel J Rawle; Fangyun Qin; Rui Wang; Dinesh C Soares; Hongping Jin; Haran Sivakumaran; Min-Hsuan Lin; Kirsten Spann; Catherine M Abbott; David Harrich
Journal:  PLoS Pathog       Date:  2015-12-01       Impact factor: 6.823

9.  Isolated HIV-1 core is active for reverse transcription.

Authors:  David Warrilow; Deborah Stenzel; David Harrich
Journal:  Retrovirology       Date:  2007-10-24       Impact factor: 4.602

10.  HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells.

Authors:  Julie Lemay; Priscilla Maidou-Peindara; Thomas Bader; Eric Ennifar; Jean-Christophe Rain; Richard Benarous; Lang Xia Liu
Journal:  Retrovirology       Date:  2008-06-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.